×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Constellation Pharmaceuticals Inc. (CNST) NASDAQ/NGS (GLOBAL SELECT MARKET)

$33.99 - (-)

Market Cap: -

As of 07/14/21 12:00 AM EDT. Market closed.

(CNST)

Constellation Pharmaceuticals Inc. (CNST)
NASDAQ/NGS (GLOBAL SELECT MARKET)

$33.99
- (-)

Market Cap: -

As of 07/14/21 12:00 AM EDT. Market closed.

Add to Portfolio

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment play a fundamental role in driving disease ... read more

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment play a fundamental role in driving disease progression and drug resistance. Constellation is driving development of the BET inhibitor CPI-0610 for the treatment of myelofibrosis as well as the EZH2 inhibitor CPI-0209 for the treatment of solid tumors. The Company is also applying its broad research and development capabilities to explore other novel targets that directly and indirectly impact gene expression to fuel a sustainable pipeline of innovative small-molecule product candidates. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$427,551
CEO Compensation (Total)
$4.70M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$427,551
CEO Compensation (Total)
$4.70M
Address
.
PRICE CHART FOR CONSTELLATION PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$34
Previous Close
$33.99
Days Range
$33.97 - $34.05
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
47,914,690
Open
$34
Previous Close
$33.99
Days Range
$33.97 - $34.05
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
47,914,690
FINANCIAL STATEMENTS FOR CONSTELLATION PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CONSTELLATION PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Reeve EmmaChief Financial OfficerFeb 22, 2021 Option Exercise$8.046,26050,3306,260Feb 23, 2021, 05:58 PM
Reeve EmmaChief Financial OfficerFeb 19, 2021 Option Exercise$8.044,01032,2404,010Feb 23, 2021, 05:58 PM
Reeve EmmaChief Financial OfficerFeb 22, 2021 Sale$37.606,260235,3740Feb 23, 2021, 05:58 PM
Reeve EmmaChief Financial OfficerFeb 19, 2021 Sale$37.714,010151,2180Feb 23, 2021, 05:58 PM
COLUMN GROUP L P10% OwnerFeb 17, 2021 Sale$36.9510,000369,50399,155Feb 19, 2021, 05:32 PM
COLUMN GROUP L P10% OwnerFeb 17, 2021 Sale$36.9510,000369,50399,155Feb 19, 2021, 05:31 PM
Reeve EmmaChief Financial OfficerFeb 18, 2021 Option Exercise$8.041,1008,8441,100Feb 19, 2021, 04:17 PM
Reeve EmmaChief Financial OfficerFeb 17, 2021 Option Exercise$8.044103,296410Feb 19, 2021, 04:17 PM
Reeve EmmaChief Financial OfficerFeb 18, 2021 Sale$37.581,10041,3430Feb 19, 2021, 04:17 PM
Reeve EmmaChief Financial OfficerFeb 17, 2021 Sale$37.5641015,3980Feb 19, 2021, 04:17 PM
Valentine KarenSee RemarksJan 19, 2021 Option Exercise$11.5017,203197,83517,203Jan 20, 2021, 05:56 PM
Valentine KarenSee RemarksJan 19, 2021 Sale$33.9717,203584,4638,430Jan 20, 2021, 05:56 PM
GOLDSMITH MARK ADirectorDec 21, 2020 Sale$35.024,020140,769139,043Dec 28, 2020, 04:02 PM
Reeve EmmaChief Financial OfficerDec 21, 2020 Option Exercise$6.815,72038,9755,720Dec 22, 2020, 04:53 PM
Reeve EmmaChief Financial OfficerDec 21, 2020 Sale$35.115,720200,8050Dec 22, 2020, 04:53 PM
COLUMN GROUP L P10% OwnerDec 14, 2020 Option Exercise$1.5530,10746,6662,584,957Dec 16, 2020, 06:42 PM
COLUMN GROUP L P10% OwnerDec 14, 2020 Option Exercise$1.5530,10746,6662,584,957Dec 16, 2020, 06:40 PM
Reeve EmmaChief Financial OfficerJun 08, 2020 Option Exercise$7.605894,476589Jun 10, 2020, 06:50 PM
Reeve EmmaChief Financial OfficerJun 08, 2020 Sale$37.5558922,118377Jun 10, 2020, 06:50 PM
Audia James EDirectorMay 12, 2020 Sale$50.106,100305,62225,434May 13, 2020, 06:30 PM
Senderowicz AdrianChief Medical OfficerMay 12, 2020 Option Exercise$5.519,35751,55725,241May 13, 2020, 06:30 PM
Senderowicz AdrianChief Medical OfficerMay 12, 2020 Sale$50.189,357469,48815,884May 13, 2020, 06:30 PM
GOLDSMITH MARK ADirectorMay 12, 2020 Option Exercise$4.124,22517,399147,288May 13, 2020, 06:29 PM
GOLDSMITH MARK ADirectorMay 11, 2020 Option Exercise$1.55100155143,163May 13, 2020, 06:29 PM
GOLDSMITH MARK ADirectorMay 11, 2020 Sale$50.001005,000143,063May 13, 2020, 06:29 PM
GOLDSMITH MARK ADirectorMay 12, 2020 Sale$50.054,225211,474143,063May 13, 2020, 06:29 PM
Raythatha JigarSee RemarksMay 12, 2020 Option Exercise$5.519,20950,74224,170May 13, 2020, 06:25 PM
Raythatha JigarSee RemarksMay 11, 2020 Option Exercise$5.512614314,987May 13, 2020, 06:25 PM
Raythatha JigarSee RemarksMay 12, 2020 Sale$50.179,209461,98114,961May 13, 2020, 06:25 PM
Raythatha JigarSee RemarksMay 11, 2020 Sale$50.00261,30014,961May 13, 2020, 06:25 PM
Reeve EmmaChief Financial OfficerMay 11, 2020 Option Exercise$8.9216,062143,26916,062May 12, 2020, 09:41 PM
Reeve EmmaChief Financial OfficerMay 08, 2020 Option Exercise$9.8512,741125,46712,741May 12, 2020, 09:41 PM
Reeve EmmaChief Financial OfficerMay 11, 2020 Sale$49.5316,062795,6230May 12, 2020, 09:41 PM
Reeve EmmaChief Financial OfficerMay 08, 2020 Sale$49.5312,741631,0550May 12, 2020, 09:41 PM
Trojer PatrickChief Scientific OfficerMay 06, 2020 Option Exercise$7.0410,00070,38510,000May 07, 2020, 04:39 PM
Trojer PatrickChief Scientific OfficerMay 06, 2020 Sale$45.1610,000451,5530May 07, 2020, 04:39 PM
Valentine KarenSee RemarksMay 06, 2020 Option Exercise$10.9612,566137,74912,566May 07, 2020, 04:34 PM
Valentine KarenSee RemarksMay 05, 2020 Option Exercise$11.504,74454,5564,744May 07, 2020, 04:34 PM
Valentine KarenSee RemarksMay 06, 2020 Sale$40.1012,566503,8970May 07, 2020, 04:34 PM
Valentine KarenSee RemarksMay 05, 2020 Sale$40.014,744189,8170May 07, 2020, 04:34 PM
Audia James EDirectorMay 06, 2020 Sale$45.157,500338,59931,534May 07, 2020, 04:28 PM
GOLDSMITH MARK ADirectorMay 05, 2020 Option Exercise$3.503,14511,006146,208May 07, 2020, 04:25 PM
GOLDSMITH MARK ADirectorMay 06, 2020 Option Exercise$4.2611,46348,825154,526May 07, 2020, 04:25 PM
GOLDSMITH MARK ADirectorMay 05, 2020 Sale$40.013,145125,824143,063May 07, 2020, 04:25 PM
GOLDSMITH MARK ADirectorMay 06, 2020 Sale$45.0611,463516,545143,063May 07, 2020, 04:25 PM
GOLDSMITH MARK ADirectorApr 27, 2020 Option Exercise$1.55400620143,463Apr 29, 2020, 08:20 PM
GOLDSMITH MARK ADirectorApr 27, 2020 Sale$40.1240016,049143,063Apr 29, 2020, 08:20 PM
Valentine KarenSee RemarksApr 27, 2020 Option Exercise$11.504004,600400Apr 29, 2020, 08:03 PM
Valentine KarenSee RemarksApr 27, 2020 Sale$40.1340016,0520Apr 29, 2020, 08:03 PM
Valentine KarenSee RemarksApr 20, 2020 Option Exercise$11.507899,074789Apr 22, 2020, 08:17 PM
Valentine KarenSee RemarksApr 20, 2020 Sale$33.6578926,5500Apr 22, 2020, 08:17 PM
Reeve EmmaChief Financial OfficerApr 17, 2020 Option Exercise$6.617605,024760Apr 20, 2020, 05:53 PM
Reeve EmmaChief Financial OfficerApr 17, 2020 Sale$35.2976026,8200Apr 20, 2020, 05:53 PM
Valentine KarenSee RemarksApr 16, 2020 Option Exercise$11.502,99834,4772,998Apr 20, 2020, 05:52 PM
Valentine KarenSee RemarksApr 17, 2020 Option Exercise$11.502,30026,4502,300Apr 20, 2020, 05:52 PM
Valentine KarenSee RemarksApr 16, 2020 Sale$33.572,998100,6371,043Apr 20, 2020, 05:52 PM
Valentine KarenSee RemarksApr 17, 2020 Sale$35.192,30080,9390Apr 20, 2020, 05:52 PM
Reeve EmmaChief Financial OfficerApr 14, 2020 Option Exercise$8.761,22510,7311,225Apr 16, 2020, 02:31 PM
Reeve EmmaChief Financial OfficerApr 14, 2020 Sale$35.201,22543,1230Apr 16, 2020, 02:31 PM
Valentine KarenSee RemarksApr 09, 2020 Option Exercise$8.766355,563635Apr 13, 2020, 04:56 PM
Valentine KarenSee RemarksApr 09, 2020 Sale$35.0263522,2360Apr 13, 2020, 04:56 PM
Reeve EmmaChief Financial OfficerApr 09, 2020 Option Exercise$7.787005,449589Apr 13, 2020, 04:55 PM
Reeve EmmaChief Financial OfficerApr 09, 2020 Sale$35.0270024,5130Apr 13, 2020, 04:55 PM
COLUMN GROUP L P10% OwnerMar 20, 2020 Buy$23.155,539128,2286,051,376Mar 23, 2020, 06:59 PM
COLUMN GROUP L P10% OwnerMar 19, 2020 Buy$22.3836,135808,7016,045,837Mar 23, 2020, 06:59 PM
COLUMN GROUP L P10% OwnerMar 20, 2020 Buy$23.155,539128,2286,051,376Mar 23, 2020, 06:57 PM
COLUMN GROUP L P10% OwnerMar 19, 2020 Buy$22.3836,135808,7016,045,837Mar 23, 2020, 06:57 PM
Valentine KarenSee RemarksMar 09, 2020 Option Exercise$8.766175,405617Mar 11, 2020, 04:11 PM
Valentine KarenSee RemarksMar 09, 2020 Sale$32.0361719,763465Mar 11, 2020, 04:11 PM
Reeve EmmaChief Financial OfficerFeb 12, 2020 Option Exercise$8.041,1038,8681,103Feb 14, 2020, 05:09 PM
Reeve EmmaChief Financial OfficerFeb 13, 2020 Option Exercise$8.045,52144,3895,521Feb 14, 2020, 05:09 PM
Reeve EmmaChief Financial OfficerFeb 12, 2020 Sale$35.021,10338,6240Feb 14, 2020, 05:09 PM
Reeve EmmaChief Financial OfficerFeb 13, 2020 Sale$35.065,521193,5390Feb 14, 2020, 05:09 PM
Valentine KarenSee RemarksFeb 13, 2020 Option Exercise$10.334,47346,2174,473Feb 14, 2020, 05:09 PM
Valentine KarenSee RemarksFeb 12, 2020 Option Exercise$11.501,50017,2501,500Feb 14, 2020, 05:09 PM
Valentine KarenSee RemarksFeb 13, 2020 Sale$35.074,473156,8590Feb 14, 2020, 05:09 PM
Valentine KarenSee RemarksFeb 12, 2020 Sale$35.021,50052,5270Feb 14, 2020, 05:09 PM
Valentine KarenSee RemarksFeb 11, 2020 Option Exercise$11.508,55098,3258,550Feb 13, 2020, 06:22 PM
Valentine KarenSee RemarksFeb 10, 2020 Option Exercise$11.1414,096157,03514,096Feb 13, 2020, 06:22 PM
Valentine KarenSee RemarksFeb 11, 2020 Sale$35.038,550299,5060Feb 13, 2020, 06:22 PM
Valentine KarenSee RemarksFeb 10, 2020 Sale$33.5114,096472,3570Feb 13, 2020, 06:22 PM
Reeve EmmaChief Financial OfficerFeb 10, 2020 Option Exercise$7.602001,520200Feb 12, 2020, 05:36 PM
Reeve EmmaChief Financial OfficerFeb 11, 2020 Option Exercise$7.678,64266,3087,212Feb 12, 2020, 05:36 PM
Reeve EmmaChief Financial OfficerFeb 11, 2020 Sale$35.048,642302,8160Feb 12, 2020, 05:36 PM
Reeve EmmaChief Financial OfficerFeb 10, 2020 Sale$35.002007,0000Feb 12, 2020, 05:36 PM
Valentine KarenSee RemarksFeb 11, 2020 Option Exercise$11.508,55098,3258,550Feb 12, 2020, 05:36 PM
Valentine KarenSee RemarksFeb 10, 2020 Option Exercise$11.5014,096162,10414,096Feb 12, 2020, 05:36 PM
Valentine KarenSee RemarksFeb 10, 2020 Sale$33.5114,096472,3570Feb 12, 2020, 05:36 PM
Valentine KarenSee RemarksFeb 11, 2020 Sale$35.038,550299,5060Feb 12, 2020, 05:36 PM
EVNIN ANTHONY BDirectorDec 13, 2019 Buy$34.50400,00013,800,0005,742,765Dec 16, 2019, 05:57 PM
Venrock Healthcare Capital Partners III, L.P.10% OwnerDec 13, 2019 Buy$34.50400,00013,800,0004,016,873Dec 16, 2019, 05:56 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% OwnerNov 12, 2019 Sale$32.7712,800419,4562,110,290Nov 13, 2019, 08:31 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% OwnerNov 08, 2019 Sale$30.33174,3165,287,1792,197,406Nov 13, 2019, 08:31 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% OwnerNov 12, 2019 Sale$32.7712,800419,4562,111,290Nov 12, 2019, 09:19 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% OwnerNov 08, 2019 Sale$30.261,074,31632,512,1792,197,406Nov 12, 2019, 09:19 PM
Senderowicz AdrianChief Medical OfficerNov 06, 2019 Option Exercise$5.5127,232150,04843,116Nov 08, 2019, 05:28 PM
Senderowicz AdrianChief Medical OfficerNov 06, 2019 Sale$28.1227,232765,84937,685Nov 08, 2019, 05:28 PM
Reeve EmmaChief Financial OfficerNov 06, 2019 Option Exercise$6.7565,626442,78165,626Nov 08, 2019, 05:01 PM
Reeve EmmaChief Financial OfficerNov 06, 2019 Sale$21.5065,6261,410,77563,052Nov 08, 2019, 05:01 PM
Trojer PatrickChief Scientific OfficerNov 06, 2019 Option Exercise$6.1237,920231,89046,142Nov 08, 2019, 05:01 PM
Trojer PatrickChief Scientific OfficerNov 06, 2019 Sale$25.0746,1421,156,85434,607Nov 08, 2019, 05:01 PM
Audia James EDirectorNov 06, 2019 Sale$18.5522,500417,41157,034Nov 08, 2019, 05:00 PM
Raythatha JigarSee RemarksNov 06, 2019 Option Exercise$5.51102,750566,153117,711Nov 08, 2019, 05:00 PM
Raythatha JigarSee RemarksNov 06, 2019 Sale$28.33102,7502,911,381100,331Nov 08, 2019, 05:00 PM
Reeve EmmaChief Financial OfficerNov 05, 2019 Option Exercise$6.611,0006,6101,000Nov 07, 2019, 04:44 PM
Reeve EmmaChief Financial OfficerNov 05, 2019 Sale$15.501,00015,5040Nov 07, 2019, 04:44 PM
Audia James EDirectorNov 05, 2019 Sale$15.012,28834,35161,534Nov 06, 2019, 04:26 PM
Trojer PatrickChief Scientific OfficerNov 05, 2019 Option Exercise$5.511,1506,3379,372Nov 06, 2019, 04:26 PM
Trojer PatrickChief Scientific OfficerNov 04, 2019 Option Exercise$5.511005518,322Nov 06, 2019, 04:26 PM
Trojer PatrickChief Scientific OfficerNov 05, 2019 Sale$15.011,15017,2568,222Nov 06, 2019, 04:26 PM
Trojer PatrickChief Scientific OfficerNov 04, 2019 Sale$15.001001,5008,222Nov 06, 2019, 04:26 PM
Trojer PatrickChief Scientific OfficerOct 22, 2019 Option Exercise$5.297,93041,97718,207Oct 24, 2019, 03:45 PM
Trojer PatrickChief Scientific OfficerOct 23, 2019 Option Exercise$5.513001,6538,522Oct 24, 2019, 03:45 PM
Trojer PatrickChief Scientific OfficerOct 23, 2019 Sale$15.203004,5598,222Oct 24, 2019, 03:45 PM
Trojer PatrickChief Scientific OfficerOct 22, 2019 Sale$15.009,985149,8028,222Oct 24, 2019, 03:45 PM
Audia James EDirectorOct 23, 2019 Sale$15.152003,02963,822Oct 24, 2019, 03:44 PM
Audia James EDirectorOct 22, 2019 Sale$15.015,01275,21364,022Oct 24, 2019, 03:44 PM
COLUMN GROUP L P10% OwnerOct 03, 2019 Buy$8.5080,000680,000159,155Oct 07, 2019, 05:35 PM
COLUMN GROUP L P10% OwnerOct 03, 2019 Buy$8.501,331,76411,319,9946,009,702Oct 07, 2019, 05:35 PM
EVNIN ANTHONY BDirectorOct 03, 2019 Buy$8.502,823,52923,999,9975,342,765Oct 04, 2019, 05:33 PM
Senderowicz AdrianChief Medical OfficerDec 13, 2018 Option Exercise$5.5115,88487,52115,884Dec 17, 2018, 04:46 PM
TEPPER ROBERT IDirectorAug 22, 2018 Option Exercise$1.5551,03279,1003,034,083Aug 24, 2018, 04:05 PM
THIRD ROCK VENTURES LP10% OwnerAug 22, 2018 Option Exercise$1.5551,03279,1003,034,083Aug 24, 2018, 04:05 PM
THIRD ROCK VENTURES LP10% OwnerJul 23, 2018 Buy$15.00266,6674,000,0052,983,051Jul 24, 2018, 07:19 PM
TEPPER ROBERT IDirectorJul 23, 2018 Buy$15.00266,6674,000,0052,983,051Jul 24, 2018, 07:15 PM
ORBIMED ADVISORS LLC10% OwnerJul 23, 2018 Buy$15.00200,0003,000,000417,921Jul 24, 2018, 04:46 PM
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% OwnerJul 23, 2018 Buy$15.00133,3331,999,9952,297,406Jul 23, 2018, 08:15 PM
Casdin Capital, LLC10% OwnerJul 23, 2018 Buy$15.00266,6674,000,005612,450Jul 23, 2018, 08:12 PM
EVNIN ANTHONY BDirectorJul 23, 2018 Buy$15.00133,3342,000,0102,519,236Jul 23, 2018, 08:04 PM
Alexandria Venture Investments, LLC10% OwnerJul 23, 2018 Buy$15.0066,6671,000,005216,304Jul 23, 2018, 04:54 PM
Flynn James E10% OwnerJul 23, 2018 Buy$15.00200,0003,000,000835,843Jul 23, 2018, 01:00 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Reeve EmmaChief Financial Officer02/22/202150,330
Reeve EmmaChief Financial Officer02/19/202132,240
Reeve EmmaChief Financial Officer02/22/2021235,374
Reeve EmmaChief Financial Officer02/19/2021151,218
COLUMN GROUP L P10% Owner02/17/2021369,503
COLUMN GROUP L P10% Owner02/17/2021369,503
Reeve EmmaChief Financial Officer02/18/20218,844
Reeve EmmaChief Financial Officer02/17/20213,296
Reeve EmmaChief Financial Officer02/18/202141,343
Reeve EmmaChief Financial Officer02/17/202115,398
Valentine KarenSee Remarks01/19/2021197,835
Valentine KarenSee Remarks01/19/2021584,463
GOLDSMITH MARK ADirector12/21/2020140,769
Reeve EmmaChief Financial Officer12/21/202038,975
Reeve EmmaChief Financial Officer12/21/2020200,805
COLUMN GROUP L P10% Owner12/14/202046,666
COLUMN GROUP L P10% Owner12/14/202046,666
Reeve EmmaChief Financial Officer06/08/20204,476
Reeve EmmaChief Financial Officer06/08/202022,118
Audia James EDirector05/12/2020305,622
Senderowicz AdrianChief Medical Officer05/12/202051,557
Senderowicz AdrianChief Medical Officer05/12/2020469,488
GOLDSMITH MARK ADirector05/12/202017,399
GOLDSMITH MARK ADirector05/11/2020155
GOLDSMITH MARK ADirector05/11/20205,000
GOLDSMITH MARK ADirector05/12/2020211,474
Raythatha JigarSee Remarks05/12/202050,742
Raythatha JigarSee Remarks05/11/2020143
Raythatha JigarSee Remarks05/12/2020461,981
Raythatha JigarSee Remarks05/11/20201,300
Reeve EmmaChief Financial Officer05/11/2020143,269
Reeve EmmaChief Financial Officer05/08/2020125,467
Reeve EmmaChief Financial Officer05/11/2020795,623
Reeve EmmaChief Financial Officer05/08/2020631,055
Trojer PatrickChief Scientific Officer05/06/202070,385
Trojer PatrickChief Scientific Officer05/06/2020451,553
Valentine KarenSee Remarks05/06/2020137,749
Valentine KarenSee Remarks05/05/202054,556
Valentine KarenSee Remarks05/06/2020503,897
Valentine KarenSee Remarks05/05/2020189,817
Audia James EDirector05/06/2020338,599
GOLDSMITH MARK ADirector05/05/202011,006
GOLDSMITH MARK ADirector05/06/202048,825
GOLDSMITH MARK ADirector05/05/2020125,824
GOLDSMITH MARK ADirector05/06/2020516,545
GOLDSMITH MARK ADirector04/27/2020620
GOLDSMITH MARK ADirector04/27/202016,049
Valentine KarenSee Remarks04/27/20204,600
Valentine KarenSee Remarks04/27/202016,052
Valentine KarenSee Remarks04/20/20209,074
Valentine KarenSee Remarks04/20/202026,550
Reeve EmmaChief Financial Officer04/17/20205,024
Reeve EmmaChief Financial Officer04/17/202026,820
Valentine KarenSee Remarks04/16/202034,477
Valentine KarenSee Remarks04/17/202026,450
Valentine KarenSee Remarks04/16/2020100,637
Valentine KarenSee Remarks04/17/202080,939
Reeve EmmaChief Financial Officer04/14/202010,731
Reeve EmmaChief Financial Officer04/14/202043,123
Valentine KarenSee Remarks04/09/20205,563
Valentine KarenSee Remarks04/09/202022,236
Reeve EmmaChief Financial Officer04/09/20205,449
Reeve EmmaChief Financial Officer04/09/202024,513
COLUMN GROUP L P10% Owner03/20/2020128,228
COLUMN GROUP L P10% Owner03/19/2020808,701
COLUMN GROUP L P10% Owner03/20/2020128,228
COLUMN GROUP L P10% Owner03/19/2020808,701
Valentine KarenSee Remarks03/09/20205,405
Valentine KarenSee Remarks03/09/202019,763
Reeve EmmaChief Financial Officer02/12/20208,868
Reeve EmmaChief Financial Officer02/13/202044,389
Reeve EmmaChief Financial Officer02/12/202038,624
Reeve EmmaChief Financial Officer02/13/2020193,539
Valentine KarenSee Remarks02/13/202046,217
Valentine KarenSee Remarks02/12/202017,250
Valentine KarenSee Remarks02/13/2020156,859
Valentine KarenSee Remarks02/12/202052,527
Valentine KarenSee Remarks02/11/202098,325
Valentine KarenSee Remarks02/10/2020157,035
Valentine KarenSee Remarks02/11/2020299,506
Valentine KarenSee Remarks02/10/2020472,357
Reeve EmmaChief Financial Officer02/10/20201,520
Reeve EmmaChief Financial Officer02/11/202066,308
Reeve EmmaChief Financial Officer02/11/2020302,816
Reeve EmmaChief Financial Officer02/10/20207,000
Valentine KarenSee Remarks02/11/202098,325
Valentine KarenSee Remarks02/10/2020162,104
Valentine KarenSee Remarks02/10/2020472,357
Valentine KarenSee Remarks02/11/2020299,506
EVNIN ANTHONY BDirector12/13/201913,800,000
Venrock Healthcare Capital Partners III, L.P.10% Owner12/13/201913,800,000
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% Owner11/12/2019419,456
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% Owner11/08/20195,287,179
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% Owner11/12/2019419,456
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% Owner11/08/201932,512,179
Senderowicz AdrianChief Medical Officer11/06/2019150,048
Senderowicz AdrianChief Medical Officer11/06/2019765,849
Reeve EmmaChief Financial Officer11/06/2019442,781
Reeve EmmaChief Financial Officer11/06/20191,410,775
Trojer PatrickChief Scientific Officer11/06/2019231,890
Trojer PatrickChief Scientific Officer11/06/20191,156,854
Audia James EDirector11/06/2019417,411
Raythatha JigarSee Remarks11/06/2019566,153
Raythatha JigarSee Remarks11/06/20192,911,381
Reeve EmmaChief Financial Officer11/05/20196,610
Reeve EmmaChief Financial Officer11/05/201915,504
Audia James EDirector11/05/201934,351
Trojer PatrickChief Scientific Officer11/05/20196,337
Trojer PatrickChief Scientific Officer11/04/2019551
Trojer PatrickChief Scientific Officer11/05/201917,256
Trojer PatrickChief Scientific Officer11/04/20191,500
Trojer PatrickChief Scientific Officer10/22/201941,977
Trojer PatrickChief Scientific Officer10/23/20191,653
Trojer PatrickChief Scientific Officer10/23/20194,559
Trojer PatrickChief Scientific Officer10/22/2019149,802
Audia James EDirector10/23/20193,029
Audia James EDirector10/22/201975,213
COLUMN GROUP L P10% Owner10/03/2019680,000
COLUMN GROUP L P10% Owner10/03/201911,319,994
EVNIN ANTHONY BDirector10/03/201923,999,997
Senderowicz AdrianChief Medical Officer12/13/201887,521
TEPPER ROBERT IDirector08/22/201879,100
THIRD ROCK VENTURES LP10% Owner08/22/201879,100
THIRD ROCK VENTURES LP10% Owner07/23/20184,000,005
TEPPER ROBERT IDirector07/23/20184,000,005
ORBIMED ADVISORS LLC10% Owner07/23/20183,000,000
REGENTS OF THE UNIVERSITY OF CALIFORNIA10% Owner07/23/20181,999,995
Casdin Capital, LLC10% Owner07/23/20184,000,005
EVNIN ANTHONY BDirector07/23/20182,000,010
Alexandria Venture Investments, LLC10% Owner07/23/20181,000,005
Flynn James E10% Owner07/23/20183,000,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR CONSTELLATION PHARMACEUTICALS INC
LOADING...